Screening of ACE inhibitory peptides in digestive products of TGase-induced GCSG and evaluation of their absorption and transport properties.
Researchers just took a deep dive into ACE inhibitory peptides hiding in modified gelatin from grass carp skin. They weren’t messing around: the team used transglutaminase (TGase) to cross-link the gelatin, then broke it down to see what potent fragments showed up. Their goal? Find peptides that block angiotensin-converting enzyme (ACE) — a hot topic for anyone interested in blood pressure pathways and bioactive peptides.
Food Chem
by Jiang C, Chen M, Huang Q et al.
“Screening of ACE inhibitory peptides in digestive products of TGase-induced GCSG and evaluation of their absorption and transport properties. Jiang C(1), Chen M(1), Huang Q(1), Liu Y(1), Rong J(1), Yang M(2), Wang X(3), Hu Y(4). Author information: (1)College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China. (2)College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; Jiangxi Provincial Key Laboratory of Natural Microbial Medicine Research; School of Pharmacy, Yichun University, Yichun, 336000, China. Electronic address: 1318776324@qq.com. (3)College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; Bioactive Peptide Technology Hubei Engineering Research Center, Jingzhou 434000, China. (4)College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; National R & D Branch Center for Conventional Freshwater Fish Processing, Wuhan 430070, China; Bioactive Peptide Technology Hubei Engineering Research Center, Jingzhou 434000, China. Electronic address: huyang@mail.hzau.edu.cn. The digestion characteristics of grass carp skin gelatin (GCSG) with varying degrees of cross-linking induced by transglutaminase (TGase) were investigated. Specific peptide segments with potential angiotensin-converting enzyme (ACE) inhibitory activity were screened from the digestive products of GCSG with a medium crosslinking degree (45.89 ± 0.99%) which had the most abundant digestive peptide segments. Then they were synthesized to confirm their ACE inhibitory efficacy. Additionally, the absorption and transport mechanisms of the active peptides were examined. The findings revealed that the resistance of cross-linked gelatin to digestion was primarily evident during the intestinal digestion phase, with no significant alterations in nutritional quality. Two specific active peptides, PK and GK, were identified, both demonstrating ACE inhibitory activity. GK exhibited greater inhibitory potency, superior permeability and higher bioavailability compared to PK. The degree of ACE inhibition remained comparable after both peptides traversed the Caco-2 monolayer membrane. PK was primarily transported via paracellular diffusion and endocytosis, whereas GK employed a mixed mechanism involving paracellular diffusion, endocytosis and the PepT1 pathway. Copyright © 2026. Published by Elsevier Ltd. Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.”
Key takeaway: Medium cross-linking (around 46%) gave the richest pool of promising peptide segments. The researchers then zeroed in, synthesized the most interesting candidates, and confirmed their ACE inhibition in vitro.
Two peptides stood out, labeled PK and GK. Both showed clear ACE inhibitory activity, but GK stole the show: higher potency, better absorption, and more bioavailability. The team ran both peptides through a Caco-2 cell test (a classic gut barrier model) and found both could cross the intestinal membrane with their ACE inhibition intact.
How do these peptides get through? PK mostly uses paracellular diffusion and endocytosis. GK is more versatile, slipping past through diffusion, endocytosis, and the PepT1 pathway. This matters for anyone studying how peptides survive digestion and reach systemic circulation.
This study is a solid reminder that the right prep method — in this case, TGase-induced cross-linking — can dramatically affect the peptide yield and properties from a protein source. It also shows the value of tracking not just activity, but also absorption and transport mechanisms.
For researchers looking to explore more bioactive peptides or design absorption-friendly sequences, the full peptide research index is worth a look. The field keeps turning up new ways to unlock functional compounds from everyday protein sources.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.